[1] Kerry Bone. Coleus: A new development in the fight against metabolic syndrome X. Townsend Letter: The Examiner of Alternative Medicine (Issue 286), 2007, 1-9
[2] Michael P. Godard, Brad A. Johnson, Scott R. Richmond. Body Composition and Hormonal Adaptations Associated with Forskolin Consumption in Overweight and Obese Men, Obesity Research, vol. 13 issue 8. doi: 10.1038/oby.2005.162
[3] S Doseyici, I Mehmetoglu, A Toker, FH Yerlikaya, E Erbay.The effects of forskolin and rolipram on cAMP, cGMP and free fatty acid levels in diet induced obesity. Biotech Histochem. 2014 Jul;89(5):388-92. PMID: 24520882. DOI: 10.3109/10520295.2014.883463
[4] A Miczke, M Szulińska. Effects of spirulina consumption on body weight, blood pressure, and endothelial function in overweight hypertensive Caucasians: a double-blind, placebo-controlled, randomized trial. Eur Rev Med Pharmacol Sci. 2016;20(1):150-6. PMID: 26813468
[5] H P Ammon , A B Müller. Forskolin: from an ayurvedic remedy to a modern agent. Planta Med. 1985 Dec;51(6):473-7. PMID: 17345261. DOI: 10.1055/s-2007-969566
[6] M P Dubey, R C Srimal, S Nityanand, B N Dhawan. Pharmacological studies on coleonol, a hypotensive diterpene from Coleus forskolii. J Ethnopharmacol. 1981 Jan;3(1):1-13. PMID: 7193263. DOI: 10.1016/0378-8741(81)90010-6
[7] Elizdath Martínez-Galero, Ricardo Pérez-Pastén et al. Preclinical antitoxic properties of Spirulina (Arthrospira). Pharmaceutical Biology. Vol. 54, 2016. Issue 8. Pages 1345-1353. doi: 0.3109/13880209.2015.1077464
[8] Yunsheng Ma, Barbara C Olendzki et al. Single-component versus multicomponent dietary goals for the metabolic syndrome: a randomized trial. Ann Intern Med. 2015 Feb 17;162(4):248-57. PMID: 25686165. PMCID: PMC4456033. DOI: 10.7326/M14-0611.
[9] Jay Udani, Ollie Tan et al. Systematic Review and Meta-Analysis of a Proprietary Alpha-Amylase Inhibitor from White Bean (Phaseolus vulgaris L.) on Weight and Fat Loss in Humans. Foods. 2018 Apr; 7(4): 63. PMID: 29677119. DOI: 10.3390/foods7040063
_270x270.png)
